CORC

在结果中检索

CORC

浏览/检索结果: 共11条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection 期刊论文
MEDICINE, 2018, 卷号: 97, 期号: 35
作者:  Zhang, Yingyu;  Xu, Hongqin;  Chi, Xiumei;  Fan, Yuxiang;  Shi, Ying
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease A meta-analysis (PRISMA) of randomized control trials 期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 49
作者:  Zhong, Sheng;  Fan, Yuxiang;  Yan, Qi;  Fan, Xingyu;  Wu, Bo
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues 期刊论文
GUT, 2016, 卷号: 65, 期号: 2
作者:  Fan, Rong;  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Bai, Xuefan
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study 期刊论文
JOURNAL OF HEPATOLOGY, 2016, 卷号: 65, 期号: 4
作者:  Sun, Jian;  Ma, Hong;  Xie, Qing;  Xie, Yao;  Sun, Yongtao
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
IFN-lambda 4 desensitizes the response to IFN-alpha treatment in chronic hepatitis C through long-term induction of USP18 期刊论文
JOURNAL OF GENERAL VIROLOGY, 2016, 卷号: 97
作者:  Niu, Junqi;  Fan, Weiguo;  Xie, Shiqi;  Zhao, Xinhao;  Li, Nan
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
The 104-Week Efficacy and Safety of Telbivudine-Based Optimization Strategy in Chronic Hepatitis B Patients: A Randomized, Controlled Study 期刊论文
HEPATOLOGY, 2014, 卷号: 59, 期号: 4
作者:  Bai, Xuefan;  Sun, Jian;  Xie, Qing;  Tan, Deming;  Ning, Qin
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 期刊论文
HEPATOLOGY, 2013, 卷号: 58
作者:  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Fan, Rong;  Tan, Deming
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文
作者:  Cheng, Jun;  Yu, Yanyan;  Wang, Hao;  Xu, Min;  Shi, Guangfeng
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B 期刊论文
LIVER INTERNATIONAL, 2011, 卷号: 31, 期号: 5
作者:  Gane, Edward J.;  Wang, Yuming;  Liaw, Yun-Fan;  Hou, JinLin;  Thongsawat, Satawat
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B 期刊论文
GASTROENTEROLOGY, 2009, 卷号: 136, 期号: 2
作者:  Liaw, Yun-Fan;  Gane, Edward;  Leung, Nancy;  Zeuzem, Stefan;  Wang, Yuming
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace